Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-000878
Filing Date
2025-02-11
Accepted
2025-02-11 15:13:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5310
  Complete submission text file 0001959173-25-000878.txt   6689
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Subject) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38276 | Film No.: 25609372
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 5TH AVENUE, 3RD FLOOR WALTHAM MA 02451
Business Address
DeLong Mark Jeffrey (Reporting) CIK: 0001856078 (see all company filings)

Type: 144